Takeda Canada Launches Digital Health Innovation Challenge to Canada’s Inspiring Tech Community
Canada’s National Strategy for Drugs for Rare Diseases Needs a Holistic Approach
Strategies for Rare Diseases: International Landscape Report
Canadian Blood Services Awards Takeda Canada Three-Year Tender for Hemophilia treatment ADYNOVATE®
Health Canada approves new indication for lung cancer treatment option ALUNBRIG®
